Plasma metabolome analysis of patients with major depressive disorder.

Noriyuki KawamuraKosaku ShinodaHajime SatoKazunori SasakiMakoto SuzukiKumi YamakiTamaki FujimoriHiroyuki YamamotoDouglas Osei-HyiamanYoshiaki Ohashi

Published in: Psychiatry and clinical neurosciences (2018)

These results suggest that plasma PEA level could be a candidate biomarker of MDD in the clinical setting. Further studies comparing MDD and mentally healthy controls are needed to confirm the utility of PEA as a biomarker for depression.

Keyphrases

major depressive disorder
bipolar disorder
depressive symptoms
sleep quality